<DOC>
	<DOCNO>NCT01782911</DOCNO>
	<brief_summary>Polycystic ovary syndrome ( PCOS ) characterize enlarged ovary , menstrual irregularity hyperandrogenism common cause oligoovulatory infertility . Insulin resistance result hyperinsulinemia also common among woman PCOS , along increase risk dyslipidemia , hypertension , diabetes related cardiovascular consequence . Resveratrol natural polyphenol anti-carcinogenic , anti-proliferative pro-apoptotic property , show decrease proliferation steroidogenesis theca cell , emerge potential therapeutic agent PCOS patient . However , little known potential beneficial effect oocyte quality well reproductive outcome , implantation pregnancy rate . The present study evaluate effect resveratrol select biochemical parameter reproductive outcome among patient PCOS undergo vitro fertilization ( IVF ) .</brief_summary>
	<brief_title>Effect Resveratrol Metabolic Parameters Oocyte Quality PCOS Patients</brief_title>
	<detailed_description />
	<mesh_term>Resveratrol</mesh_term>
	<criteria>Women age 18 40 year old . PCOS diagnosis ( accord Rotterdam criterion ) . Mild moderate male factor , tubal factor unknown infertility . Follicle stimulation hormone ( third day menstruation ) &gt; 10 milli international units/L . Endometriosis ( III IV ) . Congenital adrenal hyperplasia . Cushing syndrome . Hyperprolactinemia . Thyroid disease . Androgenic hormone secretor tumor . Patients include trial take either oral contraceptive , steroid medication could modify ovarian function , insulin sensitivity lipid metabolism 3 month onset trial . Severe male factor ( sperm concentration &lt; 5 mill/ml ) . Patients undergo oocyte vitrification avoid hyperstimulation syndrome exclude .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Androgen</keyword>
	<keyword>IVF</keyword>
	<keyword>Resveratrol</keyword>
	<keyword>PCOS .</keyword>
</DOC>